Blood biomarkers of response to concomitant intratympanic and systemic corticosteroids treatment for idiopathic sudden sensorineural hearing loss
European Archives of Oto-Rhino-Laryngology · 2026-04 · 283 (4) · 2165-2172
DOI: 10.1007/s00405-025-09904-w ↗Kurz gefasst
Fachartikel in der Zeitschrift European Archives of Oto-Rhino-Laryngology, online erschienen am 22.12.2025. Verfasst von Giancarlo Tirelli und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical, Surgical and Health Sciences, Section of Otolaryngology, University of Trieste, Strada di Fiume 447, Trieste, 34149, Italy. Hauptthemen laut MEDLINE: Hearing Loss, Sudden, Hearing Loss, Sensorineural, Glucocorticoids, Methylprednisolone. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Trieste.
Abstract (Originalsprache)
Purpose
To evaluate the prognostic value of hematological inflammatory biomarkers in predicting hearing recovery in patients with idiopathic sudden sensorineural hearing loss (ISSNHL) treated with combined systemic and intratympanic corticosteroids.
Methods
This retrospective study included 125 patients diagnosed with ISSNHL between 2012 and 2021 who received both oral prednisone and intratympanic methylprednisolone. Clinical data and pre-treatment blood samples were collected. Inflammatory indices including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), lymphocyte-to-monocyte ratio (LMR), systemic immune-inflammation index (SII), and systemic inflammation response index (SIRI) were calculated. Hearing outcomes were classified as complete, partial, or no recovery based on pure tone average (PTA) thresholds. Univariate and multivariable logistic regression analyses were performed to identify predictors of recovery.
Results
Of the 125 patients, 33 (26.4%) had no recovery, 50 (40.0%) partial recovery, and 42 (33.6%) complete recovery. Dizziness, current smoking, delayed treatment initiation (> 7 days), elevated triglycerides (≥ 98 mg/dL), and high PLR (≥ 142) were independently associated with a lower probability of hearing recovery. A higher LMR (≥ 3.0) showed a positive trend but did not reach statistical significance in adjusted models.
Conclusions
In patients with ISSNHL treated with dual-route corticosteroids, several clinical and hematologic factors, particularly elevated PLR and delayed treatment, are independently associated with reduced odds of hearing recovery. Inflammatory blood markers may serve as accessible prognostic tools to support early risk stratification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical, Surgical and Health Sciences, Section of Otolaryngology, University of Trieste, Strada di Fiume 447, Trieste, 34149, Italy.
- Department of Medical, Surgical and Health Sciences, Section of Otolaryngology, University of Trieste, Strada di Fiume 447, Trieste, 34149, Italy. paolo.boscolorizzo@units.it.
Förderung
- Università degli Studi di Trieste
Zitieren
APA
Tirelli, G., Costariol, L., Cavallo-Ronchi, F., Sia, E., Zucchini, S., & Boscolo-Rizzo, P. (2026). Blood biomarkers of response to concomitant intratympanic and systemic corticosteroids treatment for idiopathic sudden sensorineural hearing loss. European Archives of Oto-Rhino-Laryngology, 283(4), 2165-2172. https://doi.org/10.1007/s00405-025-09904-w
Vancouver
Tirelli G, Costariol L, Cavallo-Ronchi F, Sia E, Zucchini S, Boscolo-Rizzo P. Blood biomarkers of response to concomitant intratympanic and systemic corticosteroids treatment for idiopathic sudden sensorineural hearing loss. European Archives of Oto-Rhino-Laryngology. 2026;283(4):2165-2172. doi:10.1007/s00405-025-09904-w
BibTeX
@article{Tirelli2026,
author = {Tirelli, Giancarlo and Costariol, Ludovica and Cavallo-Ronchi, Federico and Sia, Egidio and Zucchini, Simone and Boscolo-Rizzo, Paolo},
title = {Blood biomarkers of response to concomitant intratympanic and systemic corticosteroids treatment for idiopathic sudden sensorineural hearing loss},
journal = {European Archives of Oto-Rhino-Laryngology},
year = {2026},
volume = {283},
number = {4},
pages = {2165--2172},
doi = {10.1007/s00405-025-09904-w}
}
EUVIMED